Acelyrin Statistics
Total Valuation
CareDx has a market cap or net worth of $662.41 million. The enterprise value is $493.83 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 53.23 million shares outstanding. The number of shares has increased by 9.79% in one year.
| Current Share Class | 53.23M |
| Shares Outstanding | 53.23M |
| Shares Change (YoY) | +9.79% |
| Shares Change (QoQ) | -1.73% |
| Owned by Insiders (%) | 2.53% |
| Owned by Institutions (%) | 105.66% |
| Float | 51.88M |
Valuation Ratios
The trailing PE ratio is 12.55 and the forward PE ratio is 15.49.
| PE Ratio | 12.55 |
| Forward PE | 15.49 |
| PS Ratio | 1.87 |
| Forward PS | 1.60 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 54.80 |
| P/OCF Ratio | 36.73 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 8.49 |
| EV / Sales | 1.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 41.58 |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.30 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.64% and return on invested capital (ROIC) is -8.17%.
| Return on Equity (ROE) | 19.64% |
| Return on Assets (ROA) | -5.85% |
| Return on Invested Capital (ROIC) | -8.17% |
| Return on Capital Employed (ROCE) | -12.15% |
| Revenue Per Employee | $524,348 |
| Profits Per Employee | $89,445 |
| Employee Count | 650 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 4.78 |
Taxes
In the past 12 months, CareDx has paid $312,000 in taxes.
| Income Tax | 312,000 |
| Effective Tax Rate | 0.53% |
Stock Price Statistics
The stock price has decreased by -53.57% in the last 52 weeks. The beta is 2.22, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | -53.57% |
| 50-Day Moving Average | 16.67 |
| 200-Day Moving Average | 19.74 |
| Relative Strength Index (RSI) | 38.05 |
| Average Volume (20 Days) | 2,434,780 |
Short Selling Information
The latest short interest is 6.40 million, so 12.02% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 6.40M |
| Short % of Shares Out | 12.02% |
| Short % of Float | 12.33% |
| Short Ratio (days to cover) | 6.71 |
Income Statement
In the last 12 months, CareDx had revenue of $340.83 million and earned $58.14 million in profits. Earnings per share was $1.00.
| Revenue | 340.83M |
| Gross Profit | 228.06M |
| Operating Income | -42.64M |
| Pretax Income | -159.61M |
| Net Income | 58.14M |
| EBITDA | -28.49M |
| EBIT | -42.64M |
| Earnings Per Share (EPS) | $1.00 |
Full Income StatementBalance Sheet
The company has $186.26 million in cash and $29.12 million in debt, giving a net cash position of $157.13 million or $2.95 per share.
| Cash & Cash Equivalents | 186.26M |
| Total Debt | 29.12M |
| Net Cash | 157.13M |
| Net Cash Per Share | $2.95 |
| Equity (Book Value) | 327.37M |
| Book Value Per Share | 6.15 |
| Working Capital | 214.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $17.72 million and capital expenditures -$5.84 million, giving a free cash flow of $11.88 million.
| Operating Cash Flow | 17.72M |
| Capital Expenditures | -5.84M |
| Free Cash Flow | 11.88M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 66.91%, with operating and profit margins of -12.51% and 17.06%.
| Gross Margin | 66.91% |
| Operating Margin | -12.51% |
| Pretax Margin | 17.15% |
| Profit Margin | 17.06% |
| EBITDA Margin | -8.36% |
| EBIT Margin | -12.51% |
| FCF Margin | 3.49% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.79% |
| Shareholder Yield | -9.79% |
| Earnings Yield | 8.93% |
| FCF Yield | 1.82% |
Analyst Forecast
The average price target for CareDx is $27.67, which is 122.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.67 |
| Price Target Difference | 122.34% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of 4.96 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.96 |
| Piotroski F-Score | 4 |
